Aspirin And Extended-release Dipyridamole Capsule
Product Images NDC 65162-596

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Aspirin And Extended-release Dipyridamole (NDC 65162-596). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amneal Pharmaceuticals Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chem Struc Dp (Aspirin And Extended Release Dipyridamole Capsules 1)

FDA Label Image

Chem Struc Asp (Aspirin And Extended Release Dipyridamole Capsules 2)

FDA Label Image

Figure 1 (Aspirin And Extended Release Dipyridamole Capsules 3)

FDA Label Image

60 Ct. (Aspirin And Extended Release Dipyridamole Capsules 4)

60 Ct. (Aspirin And Extended Release Dipyridamole Capsules 4)
NDC 65162-596-06 is a unit-of-use container of extended-release capsules containing 200mg dipyridamole and 25mg aspirin in immediate-release sugar-coated tablet form. It is used according to the accompanying prescribing information and should be stored at 20-25°C (68-77°F) with excursions permitted between 15-30°C (59-86°F) and protected from excessive moisture. It is distributed by Amneal Pharmaceuticals in Bridgewater, NJ and should be kept out of reach of children.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.